Patents by Inventor Beverly Lorell

Beverly Lorell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10232016
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: March 19, 2019
    Assignees: Acorda Therapeutics, Inc., Beth Israel Deaconess Medical Center, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer
  • Publication number: 20160113998
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Application
    Filed: September 3, 2015
    Publication date: April 28, 2016
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer
  • Patent number: 8394761
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: March 12, 2013
    Assignees: Beth Israel Deaconess Medical Center, The Brigham and Women's Hospital, Inc., Acorda Therapeutics, Inc.
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer
  • Publication number: 20120065130
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Application
    Filed: November 9, 2011
    Publication date: March 15, 2012
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer
  • Patent number: 8076283
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: December 13, 2011
    Assignees: Acorda Therapeutics, Inc., Beth Israel Deaconesss Medical Center, The Brigham and Women's Hospital, Inc.
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer
  • Publication number: 20100267618
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Application
    Filed: December 29, 2009
    Publication date: October 21, 2010
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer
  • Patent number: 7662772
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Grant
    Filed: August 22, 2003
    Date of Patent: February 16, 2010
    Assignees: Acorda Therapeutics, Inc., Beth Israel Deaconess Medical Center, The Brigham and Women's Hospital, Inc.
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer
  • Publication number: 20070196379
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Application
    Filed: August 22, 2003
    Publication date: August 23, 2007
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas Sawyer
  • Patent number: 6635249
    Abstract: The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: October 21, 2003
    Assignee: CeNes Pharmaceuticals, Inc.
    Inventors: Mark Marchionni, Ralph Kelly, Beverly Lorell, Douglas B. Sawyer